Orca Bio is a clinical-stage biotechnology company developing a pipeline of high precision allogeneic cell therapy products that are designed to safely replace patients’ diseased blood and immune system with a healthy one. Their manufacturing platform sorts donor blood with single-cell precision and a high level of purity and speed, enabling them to create proprietary, optimal therapeutic mixtures of immune and stem cells that have the potential to transform allogeneic cell therapy. Their talented team is driven by a passion for science and compassion for patients.

Pharmaceutical

Orca Bio

Ivan Dimov

Commercial Facility General Manager

James Scott McClellan

Virginia Sullivan

Tamas Blandl

Sanford Ng

Kelsey Grossman

Ethan Galloway

Dan Kirby

Josh Murray

Scott Mcclellan

Colm Hunt

Nate Fernhoff

Jeroen Bekaert

The board of directors at Orca Bio is made up of experienced professionals from a variety of industries and educational backgrounds. Many of the members are founding partners or investors in companies such as 8VC, AppDirect, and Blend Labs. The board also includes the CEO of Novartis, the CEO of H.J. Heinz Co., and the president and CEO of Nuvelution Pharmaceuticals.

Board of Directors

Leadership Team

Founding Team

Board of Directors

About

Team members

Other teams at Orca Bio

Leadership Team

Founding Team